Personnel

Pharmaceutical company names Alzheimer association president to management team

Published in Health and Medicine Week, April 4th, 2005

Voyager Pharmaceutical Corp., the biopharmaceutical company with a focus on a new treatment for Alzheimer disease (AD), announced that Sheldon Goldberg will leave his position as president and CEO of the Alzheimer's Association to join the company as a senior vice president of corporate development.

Goldberg will also support the company in its efforts to research and develop a pipeline of therapies for other diseases of aging.

Goldberg will implement key advocacy, business and public policy functions that support the company's AD therapeutic approach and anticipated pivotal studies. He brings more than 30 years experience to this new post, including...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry